A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
Yiyue Ge, Tingzhong Tian, Suling Huang…·Jianyang Zeng
This paper presents a data-driven drug repositioning framework that identifies CVL218, a PARP1 inhibitor, as a potential therapeutic for COVID-19 through in silico and experimental validation.